Department of Chemistry and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Department of Biochemistry and Centre for Ageing and Neurobiology, National University of Singapore, Singapore, Singapore.
Nat Rev Neurosci. 2019 Mar;20(3):148-160. doi: 10.1038/s41583-019-0132-6.
Alzheimer disease (AD) is a major cause of age-related dementia. We do not fully understand AD aetiology and pathogenesis, but oxidative damage is a key component. The brain mostly uses glucose for energy, but in AD and amnestic mild cognitive impairment glucose metabolism is dramatically decreased, probably owing, at least in part, to oxidative damage to enzymes involved in glycolysis, the tricarboxylic acid cycle and ATP biosynthesis. Consequently, ATP-requiring processes for cognitive function are impaired, and synaptic dysfunction and neuronal death result, with ensuing thinning of key brain areas. We summarize current research on the interplay and sequence of these processes and suggest potential pharmacological interventions to retard AD progression.
阿尔茨海默病(AD)是与年龄相关的痴呆的主要原因。我们不完全了解 AD 的病因和发病机制,但氧化损伤是一个关键组成部分。大脑主要使用葡萄糖作为能量,但在 AD 和遗忘型轻度认知障碍中,葡萄糖代谢显著降低,这可能至少部分归因于参与糖酵解、三羧酸循环和 ATP 合成的酶的氧化损伤。因此,认知功能所需的 ATP 过程受损,突触功能障碍和神经元死亡随之发生,随后关键脑区变薄。我们总结了这些过程的相互作用和顺序的当前研究,并提出了潜在的药理学干预措施来延缓 AD 的进展。